The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update
Abstract
The global issue of antimicrobial resistance poses significant challenges to public health. The World Health Organization (WHO) has highlighted it as a major global health threat, causing an estimated 700,000 deaths worldwide. Understanding the multifaceted nature of antibiotic resistance is crucial for developing effective strategies. Several physiological and biochemical mechanisms are involved in the development of antibiotic resistance. Bacterial cells may escape the bactericidal actions of the drugs by entering a physiologically dormant state known as bacterial persistence. Recent findings in this field suggest that bacterial persistence can be one of the main sources of chronic infections. The antibiotic tolerance developed by the persister cells could tolerate high levels of antibiotics and may give rise to persister offspring. These persister offspring could be attributed to antibiotic resistance mechanisms, especially in chronic infections. This review attempts to shed light on persister-induced antibiotic resistance and the current therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-tolerant persister cells arise as dormant but reversible subpopulations and are repeatedly associated with treatment failure and infection relapse [51,52,53].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
Research works printed but not linked: 132
- Ronneau, 2021, Antibiotic Persistence and Tolerance: Not Just One and the Same, Curr Opin Microbiol, 64, 76, 10.1016/j.mib.2021.09.017 · DOI
- Dawan, 2020, Role of Antibiotic Stress in Phenotypic Switching to Persister Cells of Antibiotic-Resistant Staphylococcus aureus, Ann Microbiol, 70, 1, 10.1186/s13213-020-01552-1 · DOI · Paper page
- Kalani, 2024, Are Bacterial Persister Cells Really the Cause of Infection Relapse/Recalcitrance?, J Basic Res Med Sci, 11
- Zou, 2024, Antifungal Activity, Synergism With Fluconazole or Amphotericin B and Potential Mechanism of Direct Current Against Candida Albicans Biofilms and Persisters, Antibiotics, 13, 521, 10.3390/antibiotics13060521 · DOI · Paper page
- Ahmady, 2024, Antifungal Drug Resistance in Candida: A Special Emphasis on Amphotericin B, APMIS, 132, 291, 10.1111/apm.13389 · DOI
- Baquero, 2024, Bacteriostatic Cells Instead of Bacteriostatic Antibiotics?, Mbio, 15, e0268023, 10.1128/mbio.02680-23 · doi:10.1128/mbio.02680-23
- Song, 2021, Are We Really Studying Persister Cells?, Environ Microbiol Rep, 13, 3, 10.1111/1758-2229.12849 · DOI
- Kaplan, 2021, Observation of Universal Ageing Dynamics in Antibiotic Persistence, Nature, 600, 290, 10.1038/s41586-021-04114-w · DOI
- Gollan, 2019, Bacterial Persisters and Infection: Past, Present, and Progressing, Annu Rev Microbiol, 73, 359, 10.1146/annurev-micro-020518-115650 · DOI · Paper page
- Huemer, 2021, Molecular Reprogramming and Phenotype Switching in Staphylococcus Aureus Lead to High Antibiotic Persistence and Affect Therapy Success, Proc Natl Acad Sci, 118, e2014920118, 10.1073/pnas.2014920118 · DOI
- Planet, 2022, Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung, J Pediatr Infect Dis Soc, 11, S23, 10.1093/jpids/piac073 · DOI
- Sommerfield, 2024, In Vivo and in Vitro Analysis of the Role of the Prc Protease in Inducing Mucoidy in
- Chung, 2023, How Three Self-Secreted Biofilm Exopolysaccharides of pseudomonas Aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection, Int J Mol Sci, 24, 8709, 10.3390/ijms24108709 · DOI
- Liong, 2024, Pseudomonas Aeruginosa: The Whats, Whys, and Hows of Bacterial Efflux, J High Sch Sci, 8, 122
- Kameswaran, 2024, Quenching and Quorum Sensing in Bacterial Bio-Films, Res Microbiol, 175, 104085, 10.1016/j.resmic.2023.104085 · DOI
- García-Villada, 2024, A Role for the Stringent Response in Ciprofloxacin Resistance in Pseudomonas Aeruginosa, Scientific Rep, 14, 8598, 10.1038/s41598-024-59188-z · DOI
- Gebreyohannes, 2019, Challenges of Intervention, Treatment, and Antibiotic Resistance of Biofilm-Forming Microorganisms, Heliyon, 5, e02192, 10.1016/j.heliyon.2019.e02192 · DOI · Paper page
- Conlon, 2015, Persister Cells in Biofilm Associated Infections, 1, 10.1007/978-3-319-09782-4_1 · DOI · Paper page
- Surekha, 2024, Antibiotic Resistant Biofilms and the Quest for Novel Therapeutic Strategies, Indian J Microbiol, 64, 20, 10.1007/s12088-023-01138-w · DOI
- He, 2023, Antibiotic Treatment Can Exacerbate Biofilm-Associated Infection by Promoting Quorum Cheater Development, npj Biofilms and Microbiomes, 9, 26, 10.1038/s41522-023-00394-4 · DOI
- Too, 2024, The Interconnection Between Virulence Factors, Biofilm Formation, and Horizontal Gene Transfer in Enterococcus: A Review, 10.5772/intechopen.114321 · DOI
- Li, 2023, Insights Into the Role of Extracellular Polymeric Substances (EPS) in the Spread of Antibiotic Resistance Genes, Environ Pollut, 343, 123285, 10.1016/j.envpol.2023.123285 · DOI
- Zhou, 2023, Deciphering the Distribution and Microbial Secretors of Extracellular Polymeric Substances Associated Antibiotic Resistance Genes in Tube Wall Biofilm, Sci Total Environ, 881, 163218, 10.1016/j.scitotenv.2023.163218 · DOI
- Singh, 2022, Bacterial Biofilm Infections, Their Resistance to Antibiotics Therapy and Current Treatment Strategies, Biomed Mater, 17, 022003, 10.1088/1748-605X/ac50f6 · DOI
- Lewis, 2008, Quasi-Periodic Bedding in the Sedimentary Rock Record of Mars, 1532
- Levin-Reisman, 2017, Antibiotic Tolerance Facilitates the Evolution of Resistance, Science, 355, 826, 10.1126/science.aaj2191 · DOI · Paper page
- Gutierrez, 2013, β-Lactam Antibiotics Promote Bacterial Mutagenesis Via an RpoS-Mediated Reduction in Replication Fidelity, Nat Commun, 4, 1610, 10.1038/ncomms2607 · DOI · Paper page
- Kochanowski, 2024, Bacteria Colonies Modify Their Shear and Compressive Mechanical Properties in Response to Different Growth Substrates, ACS Appl Bio Mater, 10.1021/acsabm.3c00907 · DOI
- Grande, 2020, Antibiotic Resistance and Bacterial Biofilm, Expert Opin Ther Patents, 30, 897, 10.1080/13543776.2020.1830060 · DOI
- Ali, 2023, Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies, Microorganisms, 11, 1934, 10.3390/microorganisms11081934 · DOI
- Perikleous, 2023, Antibiotic Resistance in Patients With Cystic Fibrosis: Past, Present, and Future, Antibiotics, 12, 217, 10.3390/antibiotics12020217 · DOI
- Herrera-Hidalgo, 2023, Treatment of Enterococcus Faecalis Infective Endocarditis: A Continuing Challenge, Antibiotics, 12, 704, 10.3390/antibiotics12040704 · DOI
- Mendhe, 2023, Impact of Biofilms on Chronic Infections and Medical Challenges, Cureus, 15, e48204, 10.7759/cureus.48204 · DOI
- Ammons, 2010, Antibiofilm Strategies and the Need for Innovations in Wound Care, Recent Pat Antiinfect Drug Discov, 5, 10, 10.2174/157489110790112581 · DOI
- Usui, 2023, Intermittent Antibiotic Treatment of Bacterial Biofilms Favors the Rapid Evolution of Resistance, Commun Biol, 6, 275, 10.1038/s42003-023-04601-y · DOI
- Chen, 2022, The Stress Response Mechanisms of Biofilm Formation Under Sub-Lethal Photocatalysis, Appl Catal B: Environ Energ, 307, 121200, 10.1016/j.apcatb.2022.121200 · DOI
- Moser, 2021, Immune Responses to Pseudomonas Aeruginosa Biofilm Infections, Front Immunol, 12, 625597, 10.3389/fimmu.2021.625597 · DOI · Paper page
- Pan, 2023, Recent Advances in Bacterial Persistence Mechanisms, Int J Mol Sci, 24, 14311, 10.3390/ijms241814311 · DOI
- Zou, 2022, Are Bacterial Persisters Dormant Cells Only?, Front Microbiol, 12, 708580, 10.3389/fmicb.2021.708580 · DOI
- Naudin, 2024, Development of an In Vitro Biofilm Model for the Study of the Impact of Fluoroquinolones on Sewer Biofilm Microbiota, Front Microbiol, 15, 1377047, 10.3389/fmicb.2024.1377047 · doi:10.3389/fmicb.2024.1377047
- Kaushik, 2022, Interaction of RecA Mediated SOS Response With Bacterial Persistence, Biofilm Formation, and Host Response, Int J Biol Macromolecules, 217, 931, 10.1016/j.ijbiomac.2022.07.176 · DOI
- Mulcahy, 2010, Emergence of Pseudomonas Aeruginosa Strains Producing High Levels of Persister Cells in Patients With Cystic Fibrosis, J Bacteriol, 192, 6191, 10.1128/JB.01651-09 · DOI · Paper page
- Kaur, 2023, Antifungal Drug-Resistance Mechanisms in Candida Biofilms, Curr Opin Microbiol, 71, 102237, 10.1016/j.mib.2022.102237 · DOI · Paper page
- Uruén, 2021, Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance, Antibiotics, 10, 3, 10.3390/antibiotics10010003 · DOI · Paper page
- Trubenová, 2022, Population Genetics, Biofilm Recalcitrance, and Antibiotic Resistance Evolution, Trends Microbiol, 30, 841, 10.1016/j.tim.2022.02.005 · DOI
- Sun, 2019, Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance, Front Microbiol, 10, 1933, 10.3389/fmicb.2019.01933 · DOI · Paper page
- Poonam, 2022, Role of Horizontal Gene Transfer in the Dissemination of Antimicrobial Resistance in Food Animal Production, Curr Opin Food Sci, 47, 100882, 10.1016/j.cofs.2022.100882 · DOI
- GlauberAraújo, 2019, The Mechanical Properties of Microbial Surfaces and Biofilms, Cell Surf, 5, 100028, 10.1016/j.tcsw.2019.100028 · DOI
- Trubenová, 2022, Population Genetics, Biofilm Recalcitrance, and Antibiotic Resistance Evolution, Trends Microbiology, 30, 841, 10.1016/j.tim.2022.02.005 · DOI
- Lebeaux, 2014, Biofilm-Related Infections: Bridging the Gap Between Clinical Management and Fundamental Aspects of Recalcitrance Toward Antibiotics, Microbiol Mol Biol Rev, 78, 510, 10.1128/MMBR.00013-14 · DOI · Paper page
- Gabrilska, 2015, Biofilm Models of Polymicrobial Infection, Future Microbiol, 10, 1997, 10.2217/fmb.15.109 · DOI
- Zhu, 2015, Physicochemical Characteristics and Microbial Community Evolution of Biofilms During the Start-Up Period in a Moving Bed Biofilm Reactor, J Bioresour Tech, 180, 345, 10.1016/j.biortech.2015.01.006 · DOI · Paper page
- Stewart, 2001, Antibiotic Resistance of Bacteria in Biofilms, Lancet, 358, 135, 10.1016/s0140-6736(01)05321-1 · DOI · Paper page
- Jensen, 2017, Antibiotics Disrupt Coordination Between Transcriptional and Phenotypic Stress Responses in Pathogenic Bacteria, Cell Rep, 20, 1705, 10.1016/j.celrep.2017.07.062 · DOI
- Singh, 2021, Bacterial Exo-Polysaccharides in Biofilms: Role in Antimicrobial Resistance and Treatments, J Genet Eng Biotechnol, 19, 140, 10.1186/s43141-021-00242-y · DOI · Paper page
- Sharma, 2019, Antibiotics Versus Biofilm: An Emerging Battleground in Microbial Communities, Antimicrob Resist Infect Control, 8, 76, 10.1186/s13756-019-0533-3 · DOI · Paper page
- Tiwari, 2024, Recent Strategies Inhibiting Quorum Sensing and Biofilm Formation in Bacteria to Combat Antibacterial Drug Resistance, 209, 10.4018/979-8-3693-1540-8.ch009 · DOI
- Ding, 2022, Subinhibitory Antibiotic Concentrations Promote the Horizontal Transfer of Plasmid-Borne Resistance Genes From Klebsiellae Pneumoniae to Escherichia Coli, Front Microbiol, 13, 1017092, 10.3389/fmicb.2022.1017092 · DOI
- Obando, 2024, Dissecting Cell Heterogeneities in Bacterial Biofilms and Their Implications for Antibiotic Tolerance, Curr Opin Microbiol, 78, 102450, 10.1016/j.mib.2024.102450 · DOI
- Pizzolato-Cezar, 2023, Bacterial Toxin-Antitoxin Systems: Novel Insights on Toxin Activation Across Populations and Experimental Shortcomings, Curr Res Microb Sci, 5, 100204, 10.1016/j.crmicr.2023.100204 · DOI
- Grabe, 2024, Molecular Stripping Underpins Derepression of a Toxin–Antitoxin System, Nat Struct Mol Biol, 31, 1050, 10.1038/s41594-024-01253-2 · doi:10.1038/s41594-024-01253-2
- Harms, 2016, Mechanisms of Bacterial Persistence During Stress and Antibiotic Exposure, Science, 354, aaf4268, 10.1126/science.aaf4268 · DOI · Paper page
- Yang, 2017, Toxin-Antitoxin Systems and Their Role in Disseminating and Maintaining Antimicrobial Resistance, FEMS Microbiol Rev, 41, 343, 10.1093/femsre/fux006 · DOI · Paper page
- Shore, 2024, Type I Toxin-Antitoxin Systems in Bacteria: From Regulation to Biological Functions, EcoSal Plus, eesp00252022, 10.1128/ecosalplus.esp-0025-2022 · DOI
- Sonika, 2023, Toxin-Antitoxin Systems in Bacterial Pathogenesis, Heliyon, 9, e14220, 10.1016/j.heliyon.2023.e14220 · DOI
- Qiu, 2022, Toxin-Antitoxin Systems: Classification, Biological Roles, and Applications, Microbiol Res, 264, 127159, 10.1016/j.micres.2022.127159 · DOI
- Harms, 2018, Toxins, Targets and Triggers: An Overview of Toxin-Antitoxin Biology, Mol Cell, 70, 768, 10.1016/j.molcel.2018.01.003 · DOI · Paper page
- Singh, 2021, Bacterial Toxin-Antitoxin Modules: Classification, Functions, and Association With Persistence, Curr Res Microb Sci, 2, 100047, 10.1016/j.crmicr.2021.100047 · DOI
- Hong, 2012, Bacterial Persistence Increases as Environmental Fitness Decreases, Microb Biotechnol, 5, 509, 10.1111/j.1751-7915.2011.00327.x · DOI · Paper page
- Al Marjani, 2020, Toxin–Antitoxin Systems and Biofilm Formation in Bacteria, Rev Res Med Microbiol, 31, 61, 10.1097/mrm.0000000000000184 · DOI
- Leszczynska, 2013, Theformation of Persister Cells in Stationary-Phase Cultures of Escherichia Coliis Associated With the Aggregation of Endogenous Proteins, PLOS ONE, 8, e54737, 10.1371/journal.pone.0054737 · DOI
- Maisonneuve, 2013, (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity, Cell, 154, 1140, 10.1016/j.cell.2013.07.048 · DOI · Paper page
- Jurėnas, 2022, Biology and Evolution of Bacterial Toxin–Antitoxin Systems, Nat Rev Microbiol, 20, 335, 10.1038/s41579-021-00661-1 · DOI · Paper page
- Cabral, 2018, Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions, Pharmaceuticals (Basel)., 11, 14, 10.3390/ph11010014 · DOI
- Maisonneuve, 2011, Bacterial Persistence by RNA Endonucleases, Proc Natl Acad Sci USA, 108, 13206, 10.1073/pnas.1100186108 · DOI · Paper page
- Fraikin, 2019, Reassessing the Role of the Type II MqsRA Toxin-Antitoxin System in Stress Response and Biofilm Formation: MqsA Is Transcriptionally Uncoupled From mqsR, mBio, 10, e02678, 10.1128/mBio.02678-19 · DOI
- Rahman, 2023, An Isogenic
- Nazari, 2024, Investigating the Effectiveness of mqsR-Peptide Nucleic Acid as a Novel Solution for the Eradication of Persister Cells in Clinical Isolates of Escherichia Coli, Clin Lab, 70, 10.7754/Clin.Lab.2023.230406 · doi:10.7754/clin.lab.2023.230406
- Bustamante, 2024, Contribution of Toxin–Antitoxin Systems to Adherent-Invasive E. Coli Pathogenesis, Microorganisms, 12, 1158, 10.3390/microorganisms12061158 · doi:10.3390/microorganisms12061158
- Edelmann, 2021, Elevated Expression of Toxin TisB Protects Persister Cells Against Ciprofloxacin But Enhances Susceptibility to Mitomycin C, Microorganisms, 9, 943, 10.3390/microorganisms9050943 · DOI
- Brown, 2019, Nitrogen Starvation Induces Persister Cell Formation in Escherichia Coli, J Bacteriol, 201, e00622, 10.1128/JB.00622-18 · doi:10.1128/jb.00622-18
- Liu, 2024, Gene Regulatory Mechanism of Mycobacterium Tuberculosis During Dormancy, Curr Issues Mol Biol, 46, 5825, 10.3390/cimb46060348 · DOI
- Zamakhaev, 2022, VapC Toxin Switches M. Smegmatis Cells Into Dormancy Through 23S rRNA Cleavage, Arch Microbiol, 205, 28, 10.1007/s00203-022-03363-1 · DOI
- Kundu, 2021, Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium Tuberculosis, Front Microbiol, 12, 642487, 10.3389/fmicb.2021.642487 · DOI
- Ehrhardt, 2023, Determinants of Persistent Salmonella Infections, Curr Opin Immunol, 82, 102306, 10.1016/j.coi.2023.102306 · DOI
- Demidenok, 2014, Toxin-Antitoxin vapBC Locus Participates in Formation of the Dormant State in Mycobacterium Smegmatis, FEMS Microbiol Lett, 352, 69, 10.1111/1574-6968.12380 · doi:10.1111/1574-6968.12380
- Slattery, 2013, Isolation of Highly Persistent Mutants of Salmonella Enterica Serovar Typhimurium Reveals a New Toxin-Antitoxin Module, J Bacteriol, 195, 647, 10.1128/JB.01397-12 · DOI
- Irving, 2021, The Stringent Response and Physiological Roles of (Pp) pGpp in Bacteria, Nat Rev Microbiol, 19, 256, 10.1038/s41579-020-00470-y · DOI · Paper page
- Pacios, 2020, (p) ppGpp and Its Role in Bacterial Persistence: New Challenges, Antimicrob Agents Chemother, 64, e01283, 10.1128/AAC.01283-20 · DOI
- Kundra, 2020, Survival of the Fittest: The Relationship of (P) ppGpp With Bacterial Virulence, Front Microbiol, 11, 601417, 10.3389/fmicb.2020.601417 · DOI
- Das, 2020, (p) ppGpp Metabolism and Antimicrobial Resistance in Bacterial Pathogens, Front Microbiol, 11, 563944, 10.3389/fmicb.2020.563944 · DOI
- Kamruzzaman, 2021, Biological Functions of Type II Toxin-Antitoxin Systems in Bacteria, Microorganisms, 9, 1276, 10.3390/microorganisms9061276 · DOI
- Zhang, 2020, Type II Toxin–Antitoxin System in Bacteria: Activation, Function, and Mode of Action, Biophys Rep, 6, 68, 10.1007/s41048-020-00109-8 · DOI
- Ghazaei, 2022, Advances in the Study of Bacterial Toxins, Their Roles and Mechanisms in Pathogenesis, The Malaysian J Med Sci MJMS, 29, 4, 10.21315/mjms2022.29.1.2 · DOI
- Tu, 2020, Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems, Toxins, 12, 422, 10.3390/toxins12060422 · doi:10.3390/toxins12060422
- Kaldalu, 2020, In Vitro Studies of Persister Cells, Microbiol Mol Biol Rev, 84, e00070, 10.1128/MMBR.00070-20 · DOI
- Gelens, 2013, A General Model for Toxin-Antitoxin Module Dynamics Can Explain Persister Cell Formation in E. Coli, PLoS Comput Biol, 9, e1003190, 10.1371/journal.pcbi.1003190 · DOI
- Fasani, 2013, Molecular Mechanisms of Multiple Toxin–Antitoxin Systems Are Coordinated to Govern the Persister Phenotype, Proc Natl Acad Sci USA, 110, E2528, 10.1073/pnas.1301023110 · DOI
- Windels, 2024, Antibiotic Dose and Nutrient Availability Differentially Drive the Evolution of Antibiotic Resistance and Persistence, ISME J, 18, wrae070, 10.1093/ismejo/wrae070 · DOI
- Boeck, 2023, Antibiotic Tolerance: Targeting Bacterial Survival, Curr Opin Microbiol, 74, 102328, 10.1016/j.mib.2023.102328 · DOI
- Amarh, 2019, DNA Double-Strand Break Formation and Repair as Targets for Novel Antibiotic Combination Chemotherapy, Future Sci OA, 5, FSO411, 10.2144/fsoa-2019-0034 · DOI
- Lebeaux, 2014, pH-Mediated Potentiation of Aminoglycosides Kills Bacterial Persisters and Eradicates In Vivo Biofilms, J Infect Dis, 210, 1357, 10.1093/infdis/jiu286 · DOI
- Yee, 2022, Eradication of Staphylococcus Aureus Biofilm Infection by Persister Drug Combination, Antibiotics (Basel), 11, 1278, 10.3390/antibiotics11101278 · DOI
- Mayorga-Ramos, 2023, CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance, ACS Infect Dis, 9, 1283, 10.1021/acsinfecdis.2c00649 · DOI · Paper page
- Casciaro, 2020, The Antimicrobial Peptide Temporin G: Anti-Biofilm, Anti-Persister Activities, and Potentiator Effect of Tobramycin Efficacy Against Staphylococcus Aureus, Int J Mol Sci, 21, 9410, 10.3390/ijms21249410 · DOI
- Cao, 2022, Gold Nanocluster Adjuvant Enables the Eradication of Persister Cells by Antibiotics and Abolishes the Emergence of Resistance, Nanoscale, 14, 10016, 10.1039/d2nr01003h · DOI
- Kim, 2011, Selective Killing of Bacterial Persisters by a Single Chemical Compound Without Affecting normal Antibiotic-Sensitive Cells, Antimicrob Agents Chemother, 55, 5380, 10.1128/AAC.00708-11 · DOI
- Queraltó C, 2023, Role and Regulation of Clp Proteases: A Target Against Gram-Positive Bacteria, Bacteria, 2, 21, 10.3390/bacteria2010002 · DOI
- Brötz-Oesterhelt, 2021, Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential, Front Mol Biosci, 8, 690902, 10.3389/fmolb.2021.690902 · DOI
- Mroue, 2019, Pharmacodynamics of ClpP-Activating Antibiotic Combinations Against Gram-Positive Pathogens, Antimicrob Agents Chemother, 64, e01554, 10.1128/AAC.01554-19 · DOI
- Conlon, 2013, Activated ClpP Kills Persisters and Eradicates a Chronic Biofilm Infection, Nature, 503, 365, 10.1038/nature12790 · DOI · Paper page
- Wood, 2017, Strategies for Combating Persister Cell and Biofilm Infections, Microb Biotechnol, 10, 1054, 10.1111/1751-7915.12774 · DOI
- Alnahhas, 2023, Advances in Linking Single-Cell Bacterial Stress Response to Population-Level Survival, Curr Opin Biotechnol, 79, 102885, 10.1016/j.copbio.2022.102885 · DOI
- Sulaiman, 2021, Evolution of Bacterial Tolerance Under Antibiotic Treatment and Its Implications on the Development of Resistance, Front Microbiol, 12, 617412, 10.3389/fmicb.2021.617412 · DOI
- Martinecz, 2018, Estimating Treatment Prolongation for Persistent Infections, Pathog Dis, 76, fty065, 10.1093/femspd/fty065 · DOI
- Byndloss, 2016, Chronic Bacterial Pathogens: Mechanisms of Persistence, Microbiol Spectr, 4, 10, 10.1128/microbiolspec.VMBF-0020-2015 · DOI
- Joseph, 2024, Bacterial Persistence in Urinary Tract Infection Among Postmenopausal Population, Urogynecology, 30, 205, 10.1097/SPV.0000000000001452 · DOI
- Chebotar, 2021, The Classification of Bacterial Survival Strategies in the Presence of Antimicrobials, Microb Pathogenesis, 155, 104901, 10.1016/j.micpath.2021.104901 · DOI
- Fisher, 2017, Persistent Bacterial Infections and Persister Cells, Nat Rev Microbiol, 15, 453, 10.1038/nrmicro.2017.42 · DOI · Paper page
- Windels, 2019, Antibiotics: Combatting Tolerance to Stop Resistance, mBio, 10, e02095, 10.1128/mBio.02095-19 · DOI · Paper page
- Ahmed, 2024, Antimicrobial Resistance: Impacts, Challenges, and Future Prospects, J Med Surg Public Health, 2, 100081, 10.1016/j.glmedi.2024.100081 · DOI · Paper page
- Brauner, 2016, Distinguishing Between Resistance, Tolerance and Persistence to Antibiotic Treatment, Nat Rev Microbiol, 14, 320, 10.1038/nrmicro.2016.34 · DOI · Paper page
- Trastoy, 2018, Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments, Clin Microbiol Rev, 31, e00023, 10.1128/CMR.00023-18 · DOI · Paper page
- Abbas, 2024, Antibiotic Resistance: A Key Microbial Survival Mechanism That Threatens Public Health, Cell Host & Microbe, 32, 837, 10.1016/j.chom.2024.05.015 · DOI · Paper page
- Dawan, 2022, Bacterial Stress Responses as Potential Targets in Overcoming Antibiotic Resistance, Microorganisms, 10, 1385, 10.3390/microorganisms10071385 · DOI · Paper page
- Kaushik, 2022, Antipersister Strategies Against Stress Induced Bacterial Persistence, Microb Pathogenesis, 164, 105423, 10.1016/j.micpath.2022.105423 · DOI
- Bi, 2018, Stimulus Sensing and Signal Processing in Bacterial Chemotaxis, Curr Opin Microbiol, 45, 22, 10.1016/j.mib.2018.02.002 · DOI · Paper page
- Amato, 2013, Metabolic Control of Persister Formation in Escherichia Coli, Mol Cell, 50, 475, 10.1016/j.molcel.2013.04.002 · DOI · Paper page
- Jiang, 2023, Ampicillin-Controlled Glucose Metabolism Manipulates the Transition From Tolerance to Resistance in Bacteria, Sci Adv, 9, eade8582, 10.1126/sciadv.ade8582 · DOI
- Li, 2019, The Resistance Mechanism of Escherichia Coli Induced by Ampicillin in Laboratory, Infect Drug Resist, 12, 2853, 10.2147/IDR.S221212 · DOI
- Huigens, 2021, Targeting Bacterial Biofilms With Persister-Killing Agents, Future Med Chem, 13, 225, 10.4155/fmc-2020-0314 · doi:10.4155/fmc-2020-0314
- Wexselblatt, 2012, Relacin, a Novel Antibacterial Agent Targeting the Stringent Response, PLoS Pathog, 8, e1002925, 10.1371/journal.ppat.1002925 · DOI · Paper page
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Kunnath, A. P., Suodha Suoodh, M., Chellappan, D. K., Chellian, J., & Palaniveloo, K.
- Venue
- British Journal of Biomedical Science
- Publisher
- Frontiers Media SA
- Published
- 2024-08-07
- Volume
- 81
- ISSN
- 2474-0896
- Cited by
- 108
- References
- 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update. https://app.cochat.ai/papers/10.3389/bjbs.2024.12958
- The paper
- Kunnath, A. P., Suodha Suoodh, M., Chellappan, D. K., Chellian, J., & Palaniveloo, K. (2024). Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update. British Journal of Biomedical Science. https://doi.org/10.3389/bjbs.2024.12958
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.